Pharmacy Times: CATALYST Trial Shows Hypercortisolism in 24% of Poorly Controlled Diabetes Patients, Opening New Treatment Avenues
Ralph DeFronzo, MD, Department of Medicine, chief of the Division of Diabetes, was quoted in this article. Read More
Share This Story